Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| To Join or Not to Join: Decision Points Along the Pathway to Double-Strand Break Repair vs. Chromosome End Protection. | Front Cell Dev Biol | 2021 | 34322492 | PubTator, text mining | PubMed |
| The repair gene BACH1 - a potential oncogene. | Oncol Rev | 2021 | 34322202 | PubTator, text mining | PubMed |
| Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma. | Cancer Res | 2021 | 34321241 | PubTator, text mining | PubMed |
| A study of elective genome sequencing and pharmacogenetic testing in an unselected population. | Mol Genet Genomic Med | 2021 | 34313030 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review. | Front Mol Biosci | 2021 | 34307454 | PubTator, text mining | PubMed |
| Expanding the genotypes and phenotypes for 19 rare diseases by exome sequencing performed in pediatric intensive care unit. | Hum Mutat | 2021 | 34298581 | PubTator, text mining | PubMed |
| Single-Molecule Techniques to Study Chromatin. | Front Cell Dev Biol | 2021 | 34291054 | PubTator, text mining | PubMed |
| The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential. | Cancer Commun (Lond) | 2021 | 34289530 | PubTator, text mining | PubMed |
| Human Radiosensitivity and Radiosusceptibility: What Are the Differences? | Int J Mol Sci | 2021 | 34281212 | PubTator, text mining | PubMed |
| Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor‑promoting factors (Review). | Oncol Rep | 2021 | 34278498 | PubTator, text mining | PubMed |
| The evolving complexity of DNA damage foci: RNA, condensates and chromatin in DNA double-strand break repair. | DNA Repair (Amst) | 2021 | 34256335 | PubTator, text mining | PubMed |
| The conserved Tpk1 regulates non-homologous end joining double-strand break repair by phosphorylation of Nej1, a homolog of the human XLF. | Nucleic Acids Res | 2021 | 34244791 | PubTator, text mining | PubMed |
| DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. | Signal Transduct Target Ther | 2021 | 34238917 | PubTator, text mining | PubMed |
| EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. | Bone Marrow Transplant | 2021 | 34226669 | PubTator, text mining | PubMed |
| PNKP is required for maintaining the integrity of progenitor cell populations in adult mice. | Life Sci Alliance | 2021 | 34226276 | PubTator, text mining | PubMed |
| A Novel Approach Integrating Hierarchical Clustering and Weighted Combination for Association Study of Multiple Phenotypes and a Genetic Variant. | Front Genet | 2021 | 34220938 | PubTator, text mining | PubMed |
A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair. | Front Immunol | 2021 | 34220820 | PubTator, text mining | PubMed |
| TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors. | Cancer Res | 2021 | 34215619 | PubTator, text mining | PubMed |
| Consequences and Resolution of Transcription-Replication Conflicts. | Life (Basel) | 2021 | 34209204 | PubTator, text mining | PubMed |
| Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy? | Cancers (Basel) | 2021 | 34208195 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=41